S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
NYSEARCA:BBC

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News

$24.83
+0.21 (+0.85%)
(As of 06/2/2023 ET)
Compare
Today's Range
$24.81
$24.83
50-Day Range
$21.24
$25.38
52-Week Range
$17.77
$29.08
Volume
1,873 shs
Average Volume
2,340 shs
Market Capitalization
$12.41 million
Assets Under Management
$12.29 million
Dividend Yield
0.00%
Net Expense Ratio
0.79%
BBC stock logo

About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.

Receive BBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter.

BBC ETF News Headlines

4 Best-Performing ETF Areas of Last Week
We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
5 Best Areas of Q3 of 2022 & Their Top ETFs
Instantly Find Hidden Trade Opportunities
There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.
Best Performing ETFs For June 2022
See More Headlines

BBC Price History

Fund Details

Issuer
Virtus
Fund Name
Virtus LifeSci Biotech Clinical Trials ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:BBC
Inception Date
12/16/2014
Fund Manager
Matthew B. Brown, Seth Kadushin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
LifeSci Biotechnology Clinical Trials Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
125

Fund Statistics

Assets Under Management
$12.29 million
Average Daily Volume
$2,946.40
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
Virtus ETF Solutions, LLC
Advisor
Virtus ETF Advisers LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ETF Distributors LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Beta
1.08
Creation Unit
50,000
Creation Fee
$500.00


Virtus LifeSci Biotech Clinical Trials ETF Expenses

TypeBBCHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.79%0.54%0.52%0.50%0.49%
Other Expenses0.00%0.41%0.48%0.64%0.51%
Total Expense0.79%0.69%0.67%0.74%0.66%
Fee Waiver0.00%-0.39%-0.49%-0.69%-0.52%
Net Expense0.79%0.60%0.58%0.57%0.55%

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings & Exposure














BBC ETF - Frequently Asked Questions

How have BBC shares performed in 2023?

Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $24.99 on January 1st, 2023. Since then, BBC stock has decreased by 0.6% and is now trading at $24.8282.
View the best growth stocks for 2023 here
.

What does BBC invest in?

Virtus LifeSci Biotech Clinical Trials ETF is a equity fund issued by Virtus. BBC focuses on health care investments and follows the LifeSci Biotechnology Clinical Trials Index. The fund's investments total to approximately $12.29 million assets under management.

What stocks does Virtus LifeSci Biotech Clinical Trials ETF hold?
What is the management fee for Virtus LifeSci Biotech Clinical Trials ETF?

Virtus LifeSci Biotech Clinical Trials ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for BBC is 0.79%.

What other stocks do shareholders of Virtus LifeSci Biotech Clinical Trials ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Clinical Trials ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Simon Property Group (SPG), Cisco Systems (CSCO), Micron Technology (MU), Alibaba Group (BABA) and Johnson & Johnson (JNJ).

What is Virtus LifeSci Biotech Clinical Trials ETF's stock symbol?

Virtus LifeSci Biotech Clinical Trials ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BBC."

How do I buy shares of Virtus LifeSci Biotech Clinical Trials ETF?

Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Virtus LifeSci Biotech Clinical Trials ETF's stock price today?

One share of BBC stock can currently be purchased for approximately $24.83.

How much money does Virtus LifeSci Biotech Clinical Trials ETF make?

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) has a market capitalization of $12.41 million.

This page (NYSEARCA:BBC) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -